Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|
Operating Income | ($260.5M) | ($406.9M) | ($577.1M) | ($584.2M) | ($235.6M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Oscar Health, Inc.'s last 12-month Operating Income is $59.5M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Oscar Health, Inc.'s Operating Income growth was N/A. The average annual Operating Income growth rates for Oscar Health, Inc. have been N/A over the past three years, N/A over the past five years.